Peroxiredoxin 3 Is a Redox-Dependent Target of Thiostrepton in Malignant Mesothelioma Cells

• Kheng Newick,

  Affiliations Department of Pathology, University of Vermont College of Medicine, Burlington, Vermont, United States of America, Vermont Cancer Center, University of Vermont, Burlington, Vermont, United States of America

  ⨯
• Brian Cunniff,

  Affiliation Department of Pathology, University of Vermont College of Medicine, Burlington, Vermont, United States of America

  ⨯
• Kelsey Preston,

  Affiliation Department of Pathology, University of Vermont College of Medicine, Burlington, Vermont, United States of America

  ⨯
• Paul Held,

  Affiliation BioTek Instruments, Winooski, Vermont, United States of America

  ⨯
• Jack Arbiser,

  Affiliation Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia, United States of America

  ⨯
• Harvey Pass,

  Affiliation Department of Cardiothoracic Surgery, New York University Langone Medical Center, New York, New York, United States of America

  ⨯
• Brooke Mossman,

  Affiliations Department of Pathology, University of Vermont College of Medicine, Burlington, Vermont, United States of America, Vermont Cancer Center, University of Vermont, Burlington, Vermont, United States of America

  ⨯
• Arti Shukla,

  Affiliations Department of Pathology, University of Vermont College of Medicine, Burlington, Vermont, United States of America, Vermont Cancer Center, University of Vermont, Burlington, Vermont, United States of America

  ⨯
• Nicholas Heintz

  * E-mail: nicholas.heintz@uvm.edu

  Affiliations Department of Pathology, University of Vermont College of Medicine, Burlington, Vermont, United States of America, Vermont Cancer Center, University of Vermont, Burlington, Vermont, United States of America

  ⨯